Pembrolizumab-Induced Eruptive Keratoacanthomas and Lichen Planus in a Lung Cancer Patient

Reports of pembrolizumab-induced lichen planus and eruptive keratoacanthomas are limited in the literature. Here, we describe the unique concurrence of both lichen planus and eruptive keratoacanthomas in a patient who received pembrolizumab for non-small cell lung cancer (NSCLC). Although several th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tembunde, Yazmeen, Dika, Marthe N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496024/
https://www.ncbi.nlm.nih.gov/pubmed/37706118
http://dx.doi.org/10.7759/cureus.43402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496024/
https://www.ncbi.nlm.nih.gov/pubmed/37706118
http://dx.doi.org/10.7759/cureus.43402

Ejemplares similares